European Neuropsychopharmacology
Volume 20 , Pages S105-S158 , April 2010

Heroin-assisted treatment in the Netherlands: History, findings, and international context

  • Peter Blanken

      Affiliations

    • Central Committee on the Treatment of Heroin Addicts (CCBH), Utrecht, The Netherlands
    • Parnassia Addiction Research Center (PARC), The Hague, The Netherlands
    • Both authors contributed equally.
    • ,
  • Wim van den Brink

      Affiliations

    • Central Committee on the Treatment of Heroin Addicts (CCBH), Utrecht, The Netherlands
    • Amsterdam Institute for Addiction Research (AIAR) and Department of Psychiatry of the Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    • Both authors contributed equally.
    • Corresponding Author InformationCorresponding author. Academic Medical Center, Department of Psychiatry, PA1-188, P.O. Box 22660, 1100 DD Amsterdam, the Netherlands. Tel.: +31 020 8913634
    • ,
  • Vincent M. Hendriks

      Affiliations

    • Central Committee on the Treatment of Heroin Addicts (CCBH), Utrecht, The Netherlands
    • Parnassia Addiction Research Center (PARC), The Hague, The Netherlands
    • ,
  • Ineke A. Huijsman

      Affiliations

    • Central Committee on the Treatment of Heroin Addicts (CCBH), Utrecht, The Netherlands
    • ,
  • Marjolein G. Klous

      Affiliations

    • Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands
    • ,
  • Elisabeth J. Rook

      Affiliations

    • Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands
    • Netherlands Medicines Evaluation Board, The Hague, The Netherlands
    • ,
  • Jennifer S. Wakelin

      Affiliations

    • Wakelin Alliance, Zwartsluis, The Netherlands
    • ,
  • Cas Barendrecht

      Affiliations

    • IVO, Addiction Research Institute, Rotterdam and Department of Public Health, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands
    • ,
  • Jos H. Beijnen

      Affiliations

    • Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands
    • ,
  • Jan M. van Ree

      Affiliations

    • Central Committee on the Treatment of Heroin Addicts (CCBH), Utrecht, The Netherlands
    • Rudolf Magnus Institute of Neuroscience, Utrecht University Medical Center, Utrecht, The Netherlands

References 

  1. Ali R , Auriacombe M , Casas M , Cottler L , Farrell M , Kleiber D . Report of the external panel on the evaluation of the Swiss scientific studies of medically prescribed narcotics to drug addicts . Sucht . 1999;45:160–170
  2. American Psychiatric Association  . Diagnostic and Statistical Manual of mental disorders . Washington, DC: American Psychiatric Association; 1994;
  3. Back, S.E., Hartwell, K., Desantis, S.M., Saladin, M., McRae-Clark, A.L., Price, K.L., Moran-Santa Maria, M.M., Baker, N.L., Spratt, E., Kreek, M.J., Brady K.T., 2009. Reactivity to laboratory stress provocation predicts relapse to cocaine. Drug Alcohol Depend. August 31. [Epub ahead of print]
  4. Bammer G , Van den Brink W , Gschwend P , Hendriks V , Rehm J . What can the Swiss and Dutch trials tell us about the potential risks associated with heroin prescribing? . Drug Alcohol Rev. . 2003;22:363–371
  5. Barber JA , Thompson SG . Analysis of cost data in randomized trials: an application of the non-parametric bootstrap . Stat. Med. . 2000;19:3219–3236
  6. Bieleman, B., Snippe, J., De Bie, E., 1995. Drugs binnen de grenzen, harddrugs en criminaliteit in Nederland; schattingen van de omvang. Intraval, Groningen/Rotterdam.
  7. Blanken P , Hendriks VM , Koeter MWJ , Van Ree JM , Van den Brink W . Matching of treatment-resistant heroin-dependent patients to medical prescription of heroin or oral methadone treatment: results from two randomized controlled trials . Addiction . 2005;100:89–95
  8. Blanken P , Hendriks VM , Van Ree JM , Van den Brink W . Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands . Addiction . 2010;105:300–308
  9. British Pharmacopoeia . London: The Stationery Office; 2004;
  10. Brooks R . EuroQol: the current state of play . Health Policy . 1996;37:53–72
  11. Buster MCA , Van Brussel GHA . Selectie van drugge-bruikers voor heroine experiment: Een vooronderzoek . Amsterdam: GG&GD Amsterdam; 1996;
  12. Buster M , Reurs H . Methadon verstrekking in Amsterdam 1997. Centrale Methadon Registratie . Amsterdam: GG&GD Amsterdam; 1998;
  13. Buster M , Rook L , Van Brussel GH , Van Ree JM , Van den Brink W . Chasing the dragon related to the impaired lung function among heroin users . Drug Alcohol Depend. . 2002;68:221–228
  14. Buster, M.C.A., Van den Brink, W., Van Brussel, G.H.A., Van Ree, J.M., 2010. Influence of treatment with inhalable heroin on pulmonary function (submitted).
  15. Central Committee on the Treatment of Heroin Addicts (CCBH), 1997. Investigating the medical prescription of heroin. A randomized trial to evaluate the effectiveness of medically co-prescribed heroin and oral methadone, compared to oral methadone alone, in chronic, treatment-refractory heroin addicts. CCBH, Utrecht.
  16. Central Committee on the Treatment of Heroin Addicts (CCBH), 2002. Medical co-prescription of heroin: two randomized controlled trials. CCBH, Utrecht.
  17. Chang YJ , Tsai CH , Chen CJ . Leukoencephalopathy after inhalation of heroin vapor . J. Formos. Med. Assoc. . 1997;96:758–760
  18. Colom, J., Trujols, J., Cases, M., 2010. A randomized phase II pilot study comparing oral diacetylmorphine, oral morphine and methadone in heroin dependent inpatients: feasibility of double-blind clinical trials with oral diacetylmorphine (submitted).
  19. Comer SD , Collins ED , MacArthur RB , Fischman MW . Comparison of intravenous and intranasal heroin self-administration by morphine-maintained humans . Psychophar-macology (Berl.) . 1999;143:327–338
  20. Crits-Christoph P, Siqueland L, Blaine J, Frank A, Luborsky L, Onken LS, et al. Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study . Arch. Gen. Psychiatry . 1999;56:493–502
  21. D'Aunno T , Vaughn TE . Variations in methadone treatment practices: results from a national study . JAMA . 1992;267:253–257
  22. DeFulio A , Donlin WD , Wong CJ , Silverman K . Employment-based abstinence reinforcement as a maintenance intervention for the treatment of cocaine dependence: a randomized controlled trial . Addiction . 2009;104:1530–1538
  23. De la Fuente L , Saavedra P , Barrio G , Royuela L , Vicente J . Temporal and geographic variations in the characteristics of heroin seized in Spain and their relation with the route of administration. Spanish Group for the Study of the Purity of Seized Drugs . Drug Alcohol Depend . 1996;40:185–194
  24. Derks JTM . De verstrekking van injecteerbare opiaten: Doelstelling van het morfine-verstrekkingsexperiment . Tijdschr. Sociale Gezondheidszorg . 1984;12:496–498
  25. Derks JTM . Het Amsterdamse morfine-verstrekkings-experiment . Utrecht: Rijksuniversiteit Utrecht; 1990;
  26. Derks JTM . The dispensing of injectable morphine in Amsterdam: experiences, results and implications for the Swiss project for the medical prescription of narcotics . In:  Rihs-Middel M editors. The Medical Prescription of Narcotics: Scientific Foundations and Practical Experiences . Seattle, WA: Hogrefe and Huber; 1997;
  27. Derogatis, L.R., SCL-90: Administration, Scoring and Procedures. Manual II. Clinical Psychometric Research, Towsen, MD.
  28. De Zwart WM , van Wamel AL . Jaarboek Verslaving 1997: Over gebruik en zorg in cijfers . Houten: Bohn Stafleu van Loghum; 1998;
  29. Dijkgraaf GW , Van der Zanden BP , De Borgie AJM , Blanken P , Van Ree JM , Van den Brink W . Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials . Br. Med. J. . 2005;327:310
  30. Dole VP , Nyswander M . A medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochloride . JAMA . 1965;193:646–650
  31. Driessen FMHM . Methadonverstrekking in Nederland . Utrecht: Bureau Driessen; 1990;
  32. Driessen FMHM . Methadoncliënten in Nederland . Utrecht: Bureau Driessen; 1992;
  33. Driessen FMHM , Völker BGM , Kregting J , Van der Lelij B . De ontwikkeling van de situatie van methadoncliënten gedurende twee jaar . Utrecht: Bureau Driessen; 1999;
  34. Dutra L , Stathopoulou G , Basden SL , Leyro TM , Powers MB , Otto MW . A meta-analytic review of psychosocial interventions for substance use disorders . Am. J. Psychiatry . 2008;165:179–187
  35. EMCDDA, 2009a. Annual report on the state of the drugs problem in Europe, Publications Office of the European Union, Luxembourg (ISBN 978-92-9168-384-0).
  36. EMCDDA, 2009b. Statistical Bulletin 2009, Publications Office of the European Union, Luxembourg.
  37. European College of Neuropsychopharmacology  . Clinical relevance of response and improvement in psychopharmacology: a statement from the ECNP. Report of Consensus Meeting . Eur. Neuropsychopharmacol. . 1995;5:531–533
  38. Farrell M , Hall W . The Swiss heroin trials: testing alternative approaches . Br. Med. J. . 1998;316:639
  39. Faupel CE . Drug availability, life structure, and situational ethics of heroin addict . Urban Life . 1987;15:395–419
  40. Ferri M , Davoli M , Perucci CA . Heroin maintenance treatment for chronic heroin dependent individuals: a Cochrane systematic review of effectiveness . J Subst. Abuse Treat. . 2006;30:63–72
  41. Fischer B, Rehm J, Kirst M, Casas M, Hall W, Krausz M, et al. Heroin-assisted treatment as a response to the public health problem of opiate dependence . Eur. J. Public Health . 2002;2:228–234
  42. Fischer B , Rehm J . Illicit opioid use and treatment for opioid dependence: challenges for Canada and beyond . Can. J. Psychiatry . 2006;51:621–623
  43. Fischer B, Oviedo-Joekes E, Blanken P, Haasen C, Rehm J, Schechter MT, et al. Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics . J. Urban Health . 2007;84:552–562
  44. Flock P . Pilot study to determine the effectiveness of diamorphine gel to control pressure ulcer pain . J. Pain Symptom Manage. . 2003;25:547–554
  45. Frei A . Economic evaluation of the Swiss project on medically prescribed heroin substitution treatment . Psychiatr. Prax. . 2001;28:S41–S44
  46. Frick U , Rehm J , Kovacic S , Ammann J , Uchtenhagen A . A prospective cohort study on orally administered heroin substitution for severely addicted opioid users . Addiction . 2006;101:1631–1639
  47. GGD Amsterdam  . Drugsproblematiek in Amsterdam . Amsterdam: GG&GD Amsterdam; 2007;
  48. Girardin F, Rentsch KM, Schwab MA, Maggiorini M, Pauli-Magnus C, Kullak-Ublick GA, et al. Pharmacokinetics of high doses of intramuscular and oral heroin in narcotic addicts . Clin. Pharmacol. Ther. . 2003;74:341–352
  49. Goldberger BA , Darwin WD , Grant TM , Allen AC , Caplan YH , Cone EJ . Measurement of heroin and its metabolites by isotope-dilution electron-impact mass spectrometry . Clin. Chem. . 1993;39:670–675
  50. Goldstein RZ , Volkow ND . Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex . Am. J. Psychiatry . 2002;159:1642–1652
  51. Goodman LS , Gilman AG . Goodman & Gilman's The Pharmacological Basis of Therapeutics . 9th edn. New York, NY: McGraw-Hill; 1996;
  52. Gopinathan C , Sockalingham I , Fung MA , Peat S , Hanna MH . A comparative study of patient-controlled epidural diamorphine, subcutaneous diamorphine and an epidural diamorphine/bupivacaine combination for postoperative pain . Eur. J. Anaesthesiol. . 2000;17:189–196
  53. Guttinger F , Gschwend P , Schulte B , Rehm J , Uchtenhagen A . Evaluating long-term effects of heroin-assisted treatment: the results of a 6-year follow-up . Eur. Addict. Res. . 2003;9:73–79
  54. Haasen C , Verthein U , Degkwitz P , Berger J , Krausz M , Naber D . Heroin-assisted treatment for opioid dependence: a randomised, controlled trial . Br. J. Psychiatry . 2007;191:55–62
  55. Haasen, C., Vertheim, U., Eiroa-Orosa, F.J., Schäfer, I., Reimer, J., 2010. Is heroin-assisted treatment effective for patients with no previous maintenance treatment? Results form the German randomized controlled trial. Eur. Addict. Res. (in press).
  56. Halbsguth U , Rentsch KM , Eich-Hochli D , Diterich I , Fattinger K . Oral diacetylmorphine (heroin) yields greater morphine bioavailability than oral morphine: bioavailability related to dosage and prior opioid exposure . Br. J. Clin. Pharmacol. . 2008;66:781–791
  57. Hallett A , O'Higgins F , Francis V , Cook TM . Patient-controlled intranasal diamorphine for postoperative pain: an acceptability study . Anaesthesia . 2000;55:532–539
  58. Hallworth SP , Fernando R , Bell R , Parry MG , Lim GH . Comparison of intrathecal and epidural diamorphine for elective caesarean section using a combined spinal-epidural technique . Br. J. Anaesth. . 1999;82:228–232
  59. Harding G . Patterns of heroin use: What do we know? . Br. J. Addict. . 1988;83:1247–1254
  60. Hartnoll RL, Mitcheson MC, Battersby A, Brown G, Ellis M, Fleming P, et al. Evaluation of heroin maintenance in controlled trial . Arch. Gen. Psychiatry . 1980;37:877–884
  61. Hays SE , Grady LT , Kruegel AV . Purity profiles for heroin, morphine, and morphine hydrochloride . J. Pharm. Sci. . 1973;62:1509–1513
  62. Hendriks VM , Van den Brink W , Blanken P , Bosman IJ , Van Ree JM . Heroin self-administration by means of “chasing the dragon”: Pharmacodynamics and bioavailability of inhaled heroin . Eur. Neuropsychopharmacol. . 2001;11:241–252
  63. Hill MD , Cooper PW , Perry JR . Chasing the dragon – neurological toxicity associated with inhalation of heroin vapour: case report . CMAJ . 2000;162:236–238
  64. Hoekstra MJ , Derks J . Verslaving, verslavingszorg en verslavingsbeleid in Nederland: een overzicht . In:  Derks J ,  Hoekstra M editor. Verslavingszorg, een vak apart . Utrecht: NcGx; 1991;
  65. Hogen Esch AJ , Van der Heide S , Van den Brink W , Van Ree JM , Bruynzeel DP , Coenraads PJ . Contact allergy and respiratory/mucosal complaints from heroin (diacetylmorphine) . Contact Dermat. . 2006;54:42–49
  66. Hosmer DW , Lemeshow S . Applied Logistic Regression . New York, NY: John Wiley; 2000;
  67. Huizer H . Analytical studies on illicit heroin. V. Efficacy Heroin-assisted treatment in the Netherlands: History, findings, and international context of volatilization during heroin smoking . Pharm Weekbl Sci . 1987;9:203–211
  68. Hull CL . Principles of Behavior . New York, NY: Appleton-Century-Crofts; 1943;
  69. Inturrisi CE , Max MB , Foley KM , Schultz M , Shin SU , Houde RW . The pharmacokinetics of heroin in patients with chronic pain . N. Engl. J. Med. . 1984;310:1213–1217
  70. Inturrisi CE , Schultz M , Shin S , Umans JG , Angel L , Simon EJ . Evidence from opiate binding studies that heroin acts through its metabolites . Life Sci. . 1983;33(Suppl. 1):773–776
  71. Judson BA , Goldstein A . Prediction of long-term outcome for heroin addicts admitted to a methadone maintenance program . Drug Alcohol Depend . 1982;10:383–391
  72. Kaa E , Bent K . Impurities, adulterants and diluents of illicit heroin in Denmark (Jutland and Funen) . Forensic Sci. Int. . 1986;31:195–210
  73. Kahan M , Srivastava A , Shen K . Why we object to NAOMI. Heroin maintenance in Canada . Can. Fam. Physician . 2006;52:709–711
  74. Kamendulis LM , Brzezinski MR , Pindel EV , Bosron WF , Dean RA . Metabolism of cocaine and heroin is catalyzed by the same human liver carboxylesterases . J. Pharmacol. Exp. Ther. . 1996;279:713–717
  75. Kendall JM , Latter VS . Intranasal diamorphine as an alternative to intramuscular morphine: pharmacokinetic and pharmacodynamic aspects . Clin. Pharmacokinet. . 2003;42:501–513
  76. Kendall JM , Reeves BC , Latter VS . Multicentre randomised controlled trial of nasal diamorphine for analgesia in children and teenagers with clinical fractures . BMJ . 2001;322:261–265
  77. Klous, M.G., 2004a. Development of diacetylmorphine preparations for prescription to opioid dependent patients. Universiteit Utrecht, Utrecht (ISBN: 90-393-3836-1).
  78. Klous MG , Bronner GM , Nuijen B , Van Ree JM , Beijnen JH . Pharmaceutical heroin for inhalation: Thermal analysis and recovery experiments after volatilisation . J. Pharm. Biomed. Anal. . 2005;39:944–950
  79. Klous MG , Lee WC , Hillebrand MJX , Van den Brink W , Van Ree JM , Beijnen JH . Analysis of diacetylmorphine, caffeine and degradation products after volatilisation of pharmaceutical heroin for inhalation . J. Anal. Toxicol. . 2006;30:6–13
  80. Klous MG , Lee WC , Van den Brink W , Van Ree JM , Beijnen JH . Volatilisation of diacetylmorphine: in vitro simulation of “chasing the dragon” . Pharmazie . 2006;61:438–445
  81. Klous MG , Nuijen B , Van den Brink W , Van Ree JM , Beijnen JH . Development and manufacture of diacetylmorphine/caffeine sachets for inhalation via ‘chasing the dragon’ by heroin addicts . Drug Dev. Ind. Pharm. . 2004;30:775–784
  82. Klous MG , Nuijen B , Van den Brink W , Van Ree JM , Beijnen JH . Pharmaceutical development of an intravenous dosage form of diacetylmorphine hydrochloride . PDA J. Pharm. Sci. Technol. . 2004;58:287–295
  83. Klous MG , Nuijen B , Van den Brink W , Van Ree JM , Beijnen JH . Process characterisation, optimisation and validation of production of diacetylmorphine/caffeine sachets: a design of experiments approach . Int. J. Pharm. . 2004;285:65–75
  84. Klous MG , Rook EJ , Hillebrand MJX , Van den Brink W , Van Ree JM , Beijnen JH . Deuterodiacetylmorphine as a marker for use of illicit heroin by addicts in a heroin-assisted treatment program . J. Anal. Toxicol. . 2005;29:564–569
  85. Klous MG , Van den Brink W , Van Ree JM , Beijnen JH . Development of pharmaceutical heroin preparations for medical co-prescription to opioid dependent patients . Drug Alcohol Depend. . 2005;80:283–295
  86. Kokkevi A , Hartgers C . EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence . Eur. Addict. Res. . 1995;1:208–210
  87. Korrelboom, K., Ten Broek, E., 2004. Geïntegreerde cognitivie gedragstherapie [Integrated cognitive behavioural therapy]. Coutinho, Muiderberg.
  88. Kokkevi A , Hartgers C . EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence . Eur. Addict. Res. . 1995;1:208–210
  89. Korf DJ . Dutch treat: formal control and illicit drug use in the Netherlands . Amsterdam: Thesis Publishers; 1995;
  90. Korf DJ , Lettink D , Bouma H . Methadondosering in Nederland: Een exploratief onderzoek verstrekkers en clienten naar hoge en lage doseringen methadon . Amsterdam: Bureau voor Onderzoek en Statistiek; 1998;
  91. Kreek MJ . Methadone-related opioid agonist pharma-cotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine . Ann. N.Y. Acad. Sci. . 2000;909:186–216
  92. Kuhn J, Lenartz D, Huff W, Lee S, Koulousakis A, Klosterkoetter J, et al. Remission of alcohol dependency following deep brain stimulation of the nucleus accumbens: valuable therapeutic implications? . J. Neurol. Neurosurg. Psychiatry . 2007;78:1152–1153
  93. LADIS  . Methadone clients in addiction care in the Netherlands (1994–2002) . Houten: Stichting IVZ; 2004;
  94. Leshner AI . Addiction is a brain disease, and it matters . Science . 1997;278:45–47
  95. Lintzeris N, Strang J, Metrebian N, Byford S, Hallam C, Lee S, et al. Methodology for the Randomised Injecting Opioid Treatment Trial (RIOTT): evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UK . Harm Reduct. J. . 2006;3:28
  96. Lockridge O , Mottershaw-Jackson N , Eckerson HW , La Du BN . Hydrolysis of diacetylmorphine (heroin) by human serum cholinesterase . J. Pharmacol. Exp. Ther. . 1980;215:1–8
  97. Magura S , Nwakeze PC , Demsky SY . Pre-and in-treatment predictors of retention in methadone treatment using survival analysis . Addiction . 1998;93:51–60
  98. Mantione M , Van den Brink W , Schuurman PR , Denys D . Smoking cessation and weight loss after chronic deep brain stimulation of the nucleus accumbens: therapeutic and research implications: case report . Neurosurgery . 2010;66:E218
  99. March JC , Oviedo-Joekes E , Perea-Milla E , Carrasco F . Controlled trial of prescribed heroin in the treatment of opioid addiction . J. Subst. Abuse Treat. . 2006;31:203–211
  100. Marissen MA , Franken IH , Waters AJ , Blanken P , Van den Brink W , Hendriks VM . Attentional bias predicts heroin relapse following treatment . Addiction . 2006;101:1306–1312
  101. Marsden J , Gossop M , Stewart D , Best D , Farrell M , Lehmann P , et al.   The Maudsley addiction profile (MAP): a brief instrument for assessing treatment outcome . Addiction . 1998;93:1857–1867
  102. Martindale: The Complete Drug Reference, Electronic version. 2009. Pharmaceutical Press, London.
  103. Masters N , Heap G , Wedly J , Moore A . Inhaled nebulised morphine and diamorphine: useful in general practice? . Practitioner . 1988;232:910–914
  104. McCusker C , Davies M . Prescribing drug of choice to illicit heroin users: the experience of a U.K. community drug team . J. Subst. Abuse Treat. . 1996;13:521–531
  105. McCoubrie R , Jeffrey D . Intravesical diamorphine for bladder spasm . J. Pain Symptom Manage. . 2003;25:1–3
  106. Medicines Evaluation Board (MEB), 2006. Public Assessment Report: Diacetylmorfine 75/100/150/200 mg, poeder voor inhalatiedamp en Diacetylmorfine HCl 3 gram, poeder voor oplossing voor injectie, RVG 33463, 33464, 33465, 33466, 33467 edn. Medicines Evaluation Board, Den Haag.
  107. Medicines Evaluation Board, 2007, Public Assessment Report “Diacetylmorphine and Diacetylmorphine HCl”. MEB, The Hague (http://db.cbg-meb.nl/Pars/h33463).
  108. MHRA, 2008. Public Assessment Report: Diamorphine hydrochloride BP 100 mg and 500 mg lyophilisate for solution for injection, PL 30956/0001-2 edn. Medicines and Healthcare Products Regulatory Agency, London.
  109. Metrebian N , Shanahan W , Wells B , Stimson GV . Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: associated health gains and harm reductions . Med. J. Aust. . 1998;168:596–600
  110. Metrebian N , Carnwath T , Stimson GV , Storz T . Survey of doctors prescribing diamorphine (heroin) to opiate-dependent drug users in the United Kingdom . Addiction . 2002;97:1155–1161
  111. Metrebian N , Carnwath Z , Mott J , Carnwath T , Stimson GV , Sell L . Patients receiving a prescription for diamorphine (heroin) in the United Kingdom . Drug Alcohol Rev. . 2006;25:115–121
  112. Mitcheson M . Drug clinics in the 1970s . In:  Strang J ,  Gossop M editor. Heroin Addiction and Drug Policy: The British System . Oxford: Oxford University Press; 1994;
  113. Miller WR . Motivational interviewing: research, practice, and puzzles . Addict. Behav. . 1996;21:835–842
  114. Miller WR , Rose GS . Toward a theory of motivational interviewing . Am. Psychol. . 2009;64:527–537
  115. Mo BP , Way EL . An assessment of inhalation as a mode of administration of heroin by addicts . J. Pharmacol. Exp. Ther. . 1966;154:142–151
  116. Moffat AC , Jackson JV , Moss MS , Widdop B . Clarke's isolation and identification of drugs . 2nd edn.. London: The Pharmaceutical Press; 1986;
  117. Morgan M . The rational use of intrathecal and extradural opioids . Br. J. Anaesth . 1989;63:165–188
  118. National Drug Monitor  . In: Drug situation 2006 . Utrecht: Trimbos Instituut; 2007;p. 185
  119. Nationale Drug Monitor, 2001. Jaarbericht 2001 [Annual Report 2001]. Trimbos Instituut, Utrecht.
  120. Nationale Drug Monitor, 2008. Jaarbericht 2007 [Annual Report 2007]. Trimbos Instituut, Utrecht. Netherlands Health Council: Committee on Pharmacological Interventions in Heroin Addicts (1995). The presciption of heroin to heroin addicts. Netherlands Health Council, The Hague (publication no. 1995/12E).
  121. O'Brien CP . Neuroplasticity in addictive disorders . Dialogues Clin. Neurosci. . 2009;11:350–353
  122. O'Doherty CA , Hall EJ , Schofield L , Zeppetella G . Drugs and syringe drivers: a survey of adult specialist palliative care practice in the United Kingdom and Eire . Palliat. Med. . 2001;15:149–154
  123. Office of National Drug Control Policy (ONDCP)  . National drug control strategy . http:/www.whitehousedrugpolicy.gov 1998;
  124. Oldendorf WH , Hyman S , Braun L , Oldendorf SZ . Blood–brain barrier: penetration of morphine, codeine, heroin, and methadone after carotid injection . Science . 1972;178:984–986
  125. Ooteman W, Naassila M, Koeter MW, Verheul R, Schippers GM, Houchi H, et al. Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators . Addict. Biol. . 2009;14:328–337
  126. Ooteman W, Verheul R, Naassila Ml, Daoust M, Schippers GM, Koeter MWJ, et al. Patient-treatment matching with anti-craving medications in alcohol-dependent patients: A review on phenotypic, endophenotypic and genetic indicators . J. Subst. Use . 2005;10:75–96
  127. Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli JR, et al. A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients . Neuropsychopharmacology . 2003;28:1546–1552
  128. Oviedo-Joekes E, Brissette S, Marsh DC, Lauzon P, Guh D, Anis A, et al. Diacetylmorphine versus methadone for the treatment of opioid addiction . N. Engl. J. Med. . 2009;361:777–786
  129. Oviedo-Joekes E, Nosyk B, Marsh DC, Guh D, Brissette S, Gartry C, et al. Scientific and political challenges in North America's first randomized controlled trial of heroin-assisted treatment for severe heroin addiction: rationale and design of the NAOMI study . Clin. Trials . 2009;6:261–271
  130. Parrino MW . State Methadone Maintenance Treatment Guidelines . Rockville, MD: Department of Health and Human Services, Center for Substance Abuse Treatment; 1992;
  131. Perea-Milla E, Ayçaguer LC, Cerdà JC, Saiz FG, Rivas-Ruiz F, Danet A, et al. Efficacy of prescribed injectable diacetylmorphine in the Andalusian trial: Bayesian analysis of responders and non-responders according to a multi domain outcome index . Trials . 2009;10:70
  132. Perger L , Rentsch KM , Kullak-Ublick GA , Verotta D , Fattinger K . Oral heroin in opioid-dependent patients: pharmacokinetic comparison of immediate and extended release tablets . Eur. J. Pharm. Sci. . 2009;36:421–432
  133. Perneger TV , Giner F , Del Rio M , Mino A . Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments . BMJ . 1998;317:8–13
  134. Petry NM, Alessi SM, Carroll KM, Hanson T, MacKinnon S, Rounsaville B, et al. Contingency management treatments: Reinforcing abstinence versus adherence with goal-related activities . J. Consult. Clin. Psychol. . 2006;74:592–601
  135. Poochikian GK , Cradock JC . Stability of Brompton mixtures: determination of heroin (diacetylmorphine) and cocaine in presence of their hydrolysis products . J. Pharm. Sci. . 1980;69:637–639
  136. Project MATCH Research Group  . Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes . J. Stud. Alcohol . 1997;58:7–29
  137. Rehm J , Gschwend P , Steffen T , Gutzwiller F , Dobbler-Mikola A , Uchtenhagen A . Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study . Lancet . 2001;358:1417–1420
  138. Rehm J , Van den Brink W . 15 years of research on prescribed heroin: How do the results of the German heroin trial fit into the puzzle of the Swiss and Dutch results? . Sucht . 2007;53:262–264
  139. Risser D, Uhl A, Stichenwirth M, Honigschnabl S, Hirz W, Schneider B, et al. Quality of heroin and heroin-related deaths from 1987 to 1995 in Vienna, Austria . Addiction . 2000;95:375–382
  140. Rogers RE, Higgins ST, Silverman K, Thomas CS, Badger GJ, Bigelow G, et al. Abstinence-contingent reinforcement and engagement in non-drug-related activities amongillicitdrugabusers . Psychol. Addict. Behav. . 2008;22:544–550
  141. Rook, E.J. (2004) Pharmacokinetics and pharmacodynamics of diacetylmorphine in opioid dependent patients. Universiteit Utrecht, Utrecht (ISBN: 90-6464-7992).
  142. Rook EJ , Huitema ADR , Van den Brink W , Van Ree JM , Beijnen JH . Population pharmacokinetics of heroin and its major metabolites . Clin. Pharmacokinet. . 2006;45:401–417
  143. Rook EJ, Van Ree JM, Van den Brink W, Hillebrand MJX, Huitema ADR, Hendriks VM, et al. Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route, in opioid dependent patients . Basic Clin. Pharmacol. Toxicol. . 2006;98:86–96
  144. Rook EJ , Van Zanten AP , Van den Brink W , Van Ree JM , Beijnen JH . Mast cell mediator tryptase levels after inhalation or intravenous administration of high doses of pharma-ceutically prepared heroin . Drug Alcohol Depend. . 2006;85:185–190
  145. Rook EJ , Huitema AD , Vanden Brink W , Hillebrand MJ , Van Ree JM , Beijnen JH . Screening for illicit heroin Heroin-assisted treatment in the Netherlands: History, findings, and international context use in patients in a heroin-assisted treatment program . J. Anal. Toxicol. . 2006;30:390–394
  146. Rook EJ , Huitema AD , Van den Brink W , Van Ree JM , Beijnen JH . Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature . Curr. Clin. Pharmacol. . 2006;1:109–118
  147. Salmon AY , Goren Z , Avissar Y , Soreq H . Human erythrocyte but not brain acetylcholinesterase hydrolyses heroin to morphine . Clin. Exp. Pharmacol. Physiol. . 1999;26:596–600
  148. Sanders JC . Paediatric regional anaesthesia, a survey of practice in the United Kingdom . Br. J. Anaesth. . 2002;89:707–710
  149. Schechter MT . NAOMI – her time has come. North American Opiate Medication Initiative . J. Urban Health . 2002;79:164–165
  150. Schechter M . North American Opiate Medication Initiative (NAOMI): Multi-Centre, Randomized Controlled Trial of Heroin-Assisted Therapy for Treatment-Resistant Injection Opiate Users . Canada: Canadian Institutes of Health Research; 2006;
  151. Schreuder, R.F, and Broex, V.M.F., 1998. Verkenning drugsbeleid in Nederland: feiten, opinies en scenario's. STG, Zoetermeer.
  152. Schulenburg J , Claes C . Gesundheitsökonomische Begleit-forschung und Spezialstudie im Rahmen des bundesdeutschen Modellprojekts zur kontrollierten Heroinvergabe an Schwerstab-hängige . http://www.heroinstudie.de/Gesundheitsoekonomie 2006;
  153. Selley DE , Cao CC , Sexton T , Schwegel JA , Martin TJ , Childers SR . Mu opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine . Biochem. Pharmacol. . 2001;62:447–455
  154. Stelten BM , Noblesse LH , Ackermans L , Temel Y , Visser-Vandewalle V . The neurosurgical treatment of addiction . Neurosurg. Focus . 2008;25:E5
  155. Sneader W . The discovery of heroin . Lancet . 1998;352:1697–1699
  156. Stalder AB . Heroin-Zigaretten. In vitro-und in vivo-Rauchstudien . Bern: Universität Bern; 1997;
  157. Stotts AL , Mooney ME , Sayre SL , Novy M , Schmitz JM , Grabowski J . Illusory predictors: Generalizability of findings in cocaine treatment retention research . Addict. Behav. . 2007;32:2819–2836
  158. Strang J , Ruben S , Farrell M , Gossop M . Prescribing heroin and other injectable drugs . In:  Strang J ,  Gossop M editor. Heroin Addiction and Drug Policy: The British System . Oxford: Oxford University Press; 1994;
  159. Strang J , Griffiths P , Gossop M . Heroin in the UK: Different forms, different origins, and the relationship to different routes of administration . Drug Alcohol Rev. . 1997;16:329–337
  160. Strang J, Marsden J, Cummins M, Farrell M, Finch E, Gossop M, et al. Randomized trial of supervised injectable versus oral methadone maintenance: report of feasibility and 6-month outcome . Addiction . 2000;95:1631–1645
  161. Strang, J., Metrebian, N., Lintzeris, N., Potts, L., Carnwath, T., Mayet, S., Williams, H., Zador, D., Evers, R., Groshkova, T., Charles, V., Martin, A., Forzisi, L., 2010. Heroin on trial: the RIOTT randomised trial of supervised injectable heroin and injectable methadone as treatment for chronic heroin addicts persistently failing in orthodox treatment. Lancet (in press).
  162. The Merck Index, 12th edn. 1996. Merck, Whitehouse Station, NJ.
  163. Trujols J , Iraurgi I . Political challenges in randomized controlled trials of heroin-assisted treatment for severe heroin addiction: a Spanish experience . Clin. Trials . 2009;6:658–659
  164. Uchtenhagen A . Diversified prescription of narcotics to heroin addicts. Basis, design, research plan . Schweiz Rundsch. Med. Prax. . 1994;83:931–936
  165. Uchtenhagen A , Gutzwiller F , Dobler-Mikola A , Blatter R . Program for a medical prescription of narcotics, interim report of the research representatives . Zürich: University of Zürich; 1996;
  166. Uchtenhagen A , Gutzwiller F , Dobler-Mikola A . Versuche für eine ärtzliche Verschreibung von Betäubungsmitteln: Zweiter Zwischenbericht der Forschungsbeauftragten . Zürich: Institut für Suchtforschung in Verbinding mit der Universität Zürich; 1996;
  167. Uchtenhagen A , Gutzwiller F , Dobler-Mikola A . Versuche für eine ärtzliche Verschreibung von Betäubungsmitteln: Abschluss-bericht der Forschungsbeauftragten . Zürich: Institute für Suchtforschung in Verbinding mit der Universität Zürich; 1997;
  168. Uchtenhagen, A., Dobler-Mikola, A., Steffen, T., Gutzwiller, F., Blattler, R., Pfeiffer, S., 1999. Prescription of Narcotics for Heroin Addicts: Main Results of the Swiss National Cohort Study. Medical Prescription of Narcotics, Vol. 1. Karger, Basel.
  169. Uchtenhagen, A., 2009. Heroin-assisted treatment in Switzerland: a case study in policy change. Addiction November 17 [Epub ahead of print].
  170. Van Brussel GHA . Evaluatieverslag Palfium behandeling voor langdurig heroïneverslaafden . Amsterdam: GG&GD Amsterdam; 1995;
  171. Van Brussel GHA . The morphine distribution program in Amsterdam: practical experiences . In:  Rihs-Middel M editors. The medical prescription of narcotics: scientific foundations and practical experiences . Seattle, WA: Hogrefe and Huber; 1997;
  172. Van Brussel GHA , Buster MCA , Van der Woude DH . Dovend vuur: jaarbericht drugsafdeling 1994–1995 . Amsterdam: GG&GD Amsterdam; 1996;
  173. Van den Brink W , Hendriks VM , Van Ree JM . Medical co-prescription of heroin to chronic, treatment-resistant methadone patients in the Netherlands . J. Drug Issues . 1999;29(3):587–608
  174. Van den Brink W , Hendriks VM , Blanken P , Koeter MWJ , Van Zwieten BJ , Van Ree JM . Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials . Br. Med. J. . 2003;330:1297
  175. Van den Brink W , Haasen C . Evidence-based treatment of opioid-dependent patients . Can. J. Psychiatry . 2006;51:635–646
  176. Van den Brink W . Heroin assisted treatment . BMJ . 2009;339:b4545
  177. Van der Lelij B , Driessen FMHM . Psychosociale hulpverlening voor de doelgroep van het heroïneverstrekkings-experiment . Utrecht: Bureau Driessen; 1998;
  178. Van der Zanden BP , Dijkgraaf MGW . Type, frequency, and costs of illegal activities by heroin addicts in the Netherlands who are eligible for medical coprescription of heroin. Internal report . Amsterdam: Academic Medical Centre, Department of Clinical Epidemiology and Biostatistics; 2004;
  179. Van der Zanden BP , Dijkgraaf MG , Blanken P , De Borgie CA , Van Ree JM , Van den Brink W . Validity of the EQ-5D as a generic health outcome instrument in a heroin-dependent population . Drug Alcohol Depend . 2006;82:111–118
  180. Van der Zanden BP , Dijkgraaf MG , Blanken P , Van Ree JM , Van den Brink W . Patterns of acquisitive crime during methadone maintenance treatment among patients eligible for heroin assisted treatment . Drug Alcohol Depend. . 2007;86:84–90
  181. Van Gageldonk A , De Zwart W , Van der Stel J , Donker M . De Nederlandse verslavingszorg: overzicht van de kennis over aanbod, vraag en effect . Utrecht: Trimbos Instituut; 1997;
  182. Van Ree JM , Slangen JL , De Wied D . Intravenous self-administration of drugs in rats . J. Pharmacol. Exp. Ther. . 1978;204:547–557
  183. Van Ree JM , Gerrits MA , Vanderschuren LJ . Opioids, reward and addiction: An encounter of biology, psychology, and medicine . Pharmacoll Rev. . 1999;51:341–396
  184. Verthein U, Bonorden-Kleij K, Degkwitz P, Dilg C, Köhler WK, Passie T, et al. Long-term effects of heroin-assisted treatment in Germany . Addiction . 2008;103:960–966
  185. Ward M , Minto G , Alexander-Williams JM . A comparison of patient-controlled analgesia administered by the intravenous or intranasal route during the early postoperative period . Anaesthesia . 2002;57:48–52
  186. Weinberg DS, Inturrisi CE, Reidenberg B, Moulin DE, Nip TJ, Wallenstein S, et al. Sublingual absorption of selected opioid analgesics . Clin. Pharmacol. Ther. . 1988;44:335–342
  187. Wilson JA , Kendall JM , Cornelius P . Intranasal diamorphine for paediatric analgesia: assessment of safety and efficacy . J. Accid. Emerg. Med. . 1997;14:70–72
  188. Wolters EC, Van Wijngaarden GK, Stam FC, Rengelink H, Lousberg RJ, Schipper ME, et al. Leucoencephalopathy after inhaling “heroin” pyrolysate . Lancet . 1982;2:1233–1237
  189. Wodak A . Public health and politics: the demise of the ACT heroin trial . Med. J. Aust. . 1997;167:348–349
  190. World Health Organization (WHO)  . Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence . Geneva: WHO; 2009;
  191. Yeh SY , Gorodetzky CW , Krebs HA . Isolation and identification of morphine 3-and 6-glucuronides, morphine 3,6-diglucuronide, morphine 3-ethereal sulfate, normorphine, and normorphine 6-glucuronide as morphine metabolites in humans . J. Pharm. Sci. . 1977;66:1288–1293
  192. Yeh SY , McQuinn RL , Gorodetzky CW . Identification of diacetylmorphine metabolites in humans . J. Pharm. Sci. . 1977;66:201–204
  193. Zelen M . A new design for randomized controlled trials . N. Engl. J. Med. . 1979;300:1242–1245
  194. Zelen M . Randomized consent designs for clinical trials: an update . Stat. Med. . 1990;9:645–646
  195. Zinberg NE . Drug, set, and setting: The basis for controlled intoxicant use . New Haven, CT: Yale University Press; 1984;
  196. Zinberg NE , Harding WM , Stelmack SM . Patterns of heroin use . Ann. N.Y. Acad. Sci. . 1978;311:10–24

 The production of this monograph was sponsored by the Central Committee on the Treatment of Heroin Addicts (CCBH), installed and funded by the Netherlands Minister of Heath, Welfare and Sports (VWS).

PII: S0924-977X(10)70001-8

doi: 10.1016/S0924-977X(10)70001-8

European Neuropsychopharmacology
Volume 20 , Pages S105-S158 , April 2010

Article Tools